Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 73

1.

Imaging necrosis during treatment is associated with worse survival in EORTC 26101 study.

Nowosielski M, Gorlia T, Bromberg JEC, Sahm F, Harting I, Kickingereder P, Brandes AA, Taphoorn MJB, Taal W, Domont J, Idbaih A, Campone M, Clement PM, Weller M, Fabbro M, Le Rhun E, Platten M, Golfinopoulos V, van den Bent MJ, Bendszus M, Wick W.

Neurology. 2019 Jun 11;92(24):e2754-e2763. doi: 10.1212/WNL.0000000000007643. Epub 2019 May 10.

PMID:
31076534
2.

Withdrawal of antiepileptic drugs in patients with low grade and anaplastic glioma after long-term seizure freedom: a prospective observational study.

Kerkhof M, Koekkoek JAF, Vos MJ, van den Bent MJ, Taal W, Postma TJ, Bromberg JEC, Kouwenhoven MCM, Dirven L, Reijneveld JC, Taphoorn MJB.

J Neurooncol. 2019 May;142(3):463-470. doi: 10.1007/s11060-019-03117-y. Epub 2019 Feb 18.

3.

Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study.

Bromberg JEC, Issa S, Bakunina K, Minnema MC, Seute T, Durian M, Cull G, Schouten HC, Stevens WBC, Zijlstra JM, Baars JW, Nijland M, Mason KD, Beeker A, van den Bent MJ, Beijert M, Gonzales M, de Jong D, Doorduijn JK.

Lancet Oncol. 2019 Feb;20(2):216-228. doi: 10.1016/S1470-2045(18)30747-2. Epub 2019 Jan 7.

PMID:
30630772
4.

MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma.

Hiemcke-Jiwa LS, Leguit RJ, Snijders TJ, Bromberg JEC, Nierkens S, Jiwa NM, Minnema MC, Huibers MMH.

Br J Haematol. 2019 Jun;185(5):974-977. doi: 10.1111/bjh.15674. Epub 2018 Nov 8. No abstract available.

PMID:
30408153
5.

Cognitive functioning and health-related quality of life in patients with newly diagnosed primary CNS lymphoma: a systematic review.

van der Meulen M, Dirven L, Habets EJJ, van den Bent MJ, Taphoorn MJB, Bromberg JEC.

Lancet Oncol. 2018 Aug;19(8):e407-e418. doi: 10.1016/S1470-2045(18)30356-5.

PMID:
30102235
6.

Lifetime Depression, Other Mental Illness, and Smoking Cessation.

Huffman AL, Bromberg JE, Augustson EM.

Am J Health Behav. 2018 Jul 1;42(4):90-101. doi: 10.5993/AJHB.42.4.9.

PMID:
29973314
7.

Flow cytometry shows added value in diagnosing lymphoma in brain biopsies.

van der Meulen M, Bromberg JEC, Lam KH, Dammers R, Langerak AW, Doorduijn JK, Kros JM, van den Bent MJ, van der Velden VHJ.

Cytometry B Clin Cytom. 2018 Nov;94(6):928-934. doi: 10.1002/cyto.b.21641. Epub 2018 Sep 3.

PMID:
29747221
8.

Comprehensive microRNA expression profiling in cerebrospinal fluid distinguishes between neurological disease classes.

Grasedieck S, Mulaw M, Sperb N, Wessinger K, Rouhi A, Bommer M, Bromberg JEC, Otto M, Tumani H, von Arnim CAF, Mertens D, Kuchenbauer F.

Neuropathol Appl Neurobiol. 2019 Apr;45(3):318-323. doi: 10.1111/nan.12491. Epub 2018 May 21. No abstract available.

PMID:
29679382
9.

Efficacy of intrathecal chemotherapy in patients with central nervous system involvement of hematological malignancies: a retrospective analysis.

Dara A, Mook BB, Doorduijn JK, van den Bent MJ, Dinmohamed AG, Bromberg JEC.

J Neurooncol. 2018 Aug;139(1):117-123. doi: 10.1007/s11060-018-2849-x. Epub 2018 Apr 9.

PMID:
29633110
10.

Primary CNS lymphoma in HIV infection.

Brandsma D, Bromberg JEC.

Handb Clin Neurol. 2018;152:177-186. doi: 10.1016/B978-0-444-63849-6.00014-1. Review.

PMID:
29604975
11.

Improved survival in primary central nervous system lymphoma up to age 70 only: a population-based study on incidence, primary treatment and survival in the Netherlands, 1989-2015.

van der Meulen M, Dinmohamed AG, Visser O, Doorduijn JK, Bromberg JEC.

Leukemia. 2017 Aug;31(8):1822-1825. doi: 10.1038/leu.2017.128. Epub 2017 Apr 28. No abstract available.

PMID:
28450731
12.

Treatment of initial parenchymal central nervous system involvement in systemic aggressive B-cell lymphoma.

Nijland M, Jansen A, Doorduijn JK, Enting RH, Bromberg JEC, Kluin-Nelemans HC.

Leuk Lymphoma. 2017 Sep;58(9):1-6. doi: 10.1080/10428194.2017.1285026. Epub 2017 Feb 6.

PMID:
28278731
13.

Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Baumert BG, Hegi ME, van den Bent MJ, von Deimling A, Gorlia T, Hoang-Xuan K, Brandes AA, Kantor G, Taphoorn MJB, Hassel MB, Hartmann C, Ryan G, Capper D, Kros JM, Kurscheid S, Wick W, Enting R, Reni M, Thiessen B, Dhermain F, Bromberg JE, Feuvret L, Reijneveld JC, Chinot O, Gijtenbeek JMM, Rossiter JP, Dif N, Balana C, Bravo-Marques J, Clement PM, Marosi C, Tzuk-Shina T, Nordal RA, Rees J, Lacombe D, Mason WP, Stupp R.

Lancet Oncol. 2016 Nov;17(11):1521-1532. doi: 10.1016/S1470-2045(16)30313-8. Epub 2016 Sep 27.

14.

Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study.

Reijneveld JC, Taphoorn MJB, Coens C, Bromberg JEC, Mason WP, Hoang-Xuan K, Ryan G, Hassel MB, Enting RH, Brandes AA, Wick A, Chinot O, Reni M, Kantor G, Thiessen B, Klein M, Verger E, Borchers C, Hau P, Back M, Smits A, Golfinopoulos V, Gorlia T, Bottomley A, Stupp R, Baumert BG.

Lancet Oncol. 2016 Nov;17(11):1533-1542. doi: 10.1016/S1470-2045(16)30305-9. Epub 2016 Sep 27.

PMID:
27686943
15.

Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study.

Doorduijn JK, van Imhoff GW, van der Holt B, Schouten HC, Schaafsma MR, MacKenzie MA, Baars JW, Kersten MJ, Lugtenburg PJ, van den Bent MJ, Enting RH, Spoelstra FM, Poortmans P, Bromberg JEC.

Hematol Oncol. 2017 Dec;35(4):497-503. doi: 10.1002/hon.2342. Epub 2016 Aug 17.

PMID:
27530779
16.

To be in pain (or not): a computer enables outpatients to inform their physician.

Oldenmenger WH, Witkamp FE, Bromberg JE, Jongen JL, Lieverse PJ, Huygen FJ, Baan MA, van Zuylen L, van der Rijt CC.

Ann Oncol. 2016 Sep;27(9):1776-81. doi: 10.1093/annonc/mdw250. Epub 2016 Jul 20.

PMID:
27443633
17.

Low-grade and anaplastic oligodendroglioma.

Van Den Bent MJ, Bromberg JE, Buckner J.

Handb Clin Neurol. 2016;134:361-80. doi: 10.1016/B978-0-12-802997-8.00022-0. Review.

PMID:
26948366
18.

Text to Quit China: An mHealth Smoking Cessation Trial.

Augustson E, Engelgau MM, Zhang S, Cai Y, Cher W, Li R, Jiang Y, Lynch K, Bromberg JE.

Am J Health Promot. 2017 May;31(3):217-225. doi: 10.4278/ajhp.140812-QUAN-399. Epub 2016 Jan 5.

19.

Neuro-oncology: The many challenges of treating elderly glioblastoma patients.

van den Bent MJ, Bromberg JE.

Nat Rev Neurol. 2015 Jul;11(7):374-5. doi: 10.1038/nrneurol.2015.82. Epub 2015 May 19. No abstract available.

PMID:
25986504
20.

Chemotherapy in glioma.

Taal W, Bromberg JE, van den Bent MJ.

CNS Oncol. 2015;4(3):179-92. doi: 10.2217/cns.15.2. Epub 2015 Apr 23. Review.

Supplemental Content

Loading ...
Support Center